Abstract
Adriamycin was given to 29 patients with Hodgkin’s disease (8 cases), reticulo- sarcoma (4 cases), lymphosarcoma (3 cases), chronic lymphatic leukemia (7 cases), chronic myeloid anemia (2 cases), acute leukemia (5 cases); 20 patients were males, 9 females. Three further patients with other solid tumors are not considered, as well as 6 more patients inadequately treated.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Bile, G., Biasi, R.D., Berardi, G. (1972). Adriamycin in Mesenchymal Tumors and Leukemias — Results of Two Years’ Research. In: Carter, S.K., Marco, A.D., Ghione, M., Krakoff, I.H., Mathé, G. (eds) International Symposium on Adriamycin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95227-2_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-95227-2_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-95229-6
Online ISBN: 978-3-642-95227-2
eBook Packages: Springer Book Archive